Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and… Grant US-11364225-B2 United States of America 21 Jun 2022
Combinations of serotonin receptor agonists for treatment of movement disorders Grant US-10632116-B2 United States of America 28 Apr 2020
Orally available pharmaceutical formulation suitable for improved management of movement… Grant US-10561618-B2 United States of America 18 Feb 2020
Combinations of serotonin receptor agonists for treatment of movement disorders Grant US-9186359-B2 United States of America 17 Nov 2015